$RDHL
Redhill Biopharma Ltd.
XNAS•Health Care•Pharmaceutical Preparations
$0.561
▼-5.28%-$0.031
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRedhill Biopharma Ltd.
XNAS•Health Care•Pharmaceutical Preparations
Why is RDHL down today? It is at $0.561 (-5.28%), and our scanner flagged it 42 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RDHL spikes, and full due diligence on RDHL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RDHL 42 times in the last 30 days. Create a free account to track $RDHL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RDHL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RDHL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystForeign issuer report (6-K), from an SEC filing. Read it →* Institutional ownership was unavailable, so float is insider-deduped only.
Across every filing on file, supply equal to 524.3% of the tradeable float is in play - 524.3% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
262,285,730,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $13.8M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Raday Gilead Officer | Sold (automatic/other) | -14.13M 232.4% of company | sold 6.1% | 218.78M | n/a | Jul 10, 26 |
Raday Gilead Officer | Sold (automatic/other) | -15.74M 258.8% of company | sold 5.7% | 261.06M | n/a | Apr 6, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on RDHL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RDHL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RDHL last traded at $0.561, down 5.28% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The RDHL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RDHL 42 times in the last 30 days.
RDHL (Redhill Biopharma Ltd.) trades on XNAS, with a market cap of about $4M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RDHL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RDHL discussion
Sign in to ask a question or join the discussion.